Study looks at safe dosages of the isotope astatine-211 for brain tumors

[News]

In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.

More... (http://www.news-medical.net/?id=34824)